comparemela.com

Latest Breaking News On - பல்கலைக்கழகம் துறை ஆஃப் வேதியியல் - Page 8 : comparemela.com

Speeding Up the Development of Novel, High Performance Polymers

Jan 30 2021 Read 2446 Times Asynt has supplied Polymer Mimetics with a range of synthetic chemistry equipment to exploit novel chemistries to produce a new generation of high-performance polymers. Polymer Mimetics is a joint venture between the University of Liverpool, and Scott Bader Company Ltd building upon a new polymerisation process developed by Professor Steve Rannard from the University’s Department of Chemistry. The technology takes widely available chemical building blocks and, in a highly scalable process, transforms them into superior performance polymeric products with the potential to engineer in degradability. Dr Paul Findlay, Chief Technology Offer at Polymer Mimetics, said: Since the 1950 s less than 10% of the billions of tons of plastic produced worldwide has been recycled - the rest has been sent to landfill or left in the natural environment. Using our new polymerisation technology, we can produce novel polymers to address some of the issues associated wit

科创企业探访系列报道之开拓药业:另辟蹊径 竞速战 疫 新药研发 _ 东方财富网

科创企业探访系列报道之开拓药业:另辟蹊径 竞速战 疫 新药研发 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Date Time £100 million donation from Ineos to create new institute to fight antimicrobial resistance A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos. Ineos, one of the world’s largest manufacturing companies, and the University of Oxford are launching a new world-leading institute to combat the growing global issue of antimicrobial resistance (AMR), which currently causes an estimated 1.5 million excess deaths each year- and could cause over 10m deaths per year by 2050. Predicted to also create a global economic toll of $100 trillion by mid-century, it is arguably the greatest economic and healthcare challenge facing the world post-Covid.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.